國華(00370.HK):供股及配售事項成為無條件
格隆匯7月13日丨國華(00370.HK)宣佈,於2021年7月12日(星期一)下午四時正(即配售代理根據配售協議配售未獲認購供股股份的最後時限),269,992,110股未獲認購供股股份已按配售價每股配售股份0.2港元(等於認購價)成功配售予不少於六名承配人。因此,根據補償安排概無淨收益可供分派予不行動股東。
供股章程所載有關供股及配售事項的所有條件已獲達成,供股及配售事項於2021年7月13日(星期二)下午四時正成為無條件。供股(包括配售事項)籌集的所得款項總額為約101,700,000港元(扣除開支前)。
供股股份(以繳足股款的形式)及配售股份預期將於2021年7月15日(星期四)上午九時正開始於聯交所買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.